These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 2458711)
21. A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor. Law A; Scott J J Lipid Res; 1990 Jun; 31(6):1109-20. PubMed ID: 2373961 [TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody 5A binds apolipoprotein B-48 and inhibits the low density lipoprotein-receptor interaction. Corsini A; Fantappiè S; Marcovina S; Granata A; Fumagalli R; Catapano AL Biochem Biophys Res Commun; 1989 Aug; 162(3):908-15. PubMed ID: 2475112 [TBL] [Abstract][Full Text] [Related]
23. Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells. Kleinman Y; Krul ES; Burnes M; Aronson W; Pfleger B; Schonfeld G J Lipid Res; 1988 Jun; 29(6):729-43. PubMed ID: 2459282 [TBL] [Abstract][Full Text] [Related]
24. High carbohydrate fat-free diet modulates epitope expression of LDL-apoB-100 and interaction of LDL with human fibroblasts. Keidar S; Goldberg AC; Cook K; Bateman J; Schonfeld G J Lipid Res; 1989 Sep; 30(9):1131-9. PubMed ID: 2480987 [TBL] [Abstract][Full Text] [Related]
25. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products. Wang X; Bucala R; Milne R Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7643-7. PubMed ID: 9636203 [TBL] [Abstract][Full Text] [Related]
26. Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody. Gherardi E; Bowyer DE; Fitzsimmons C; Le Cras T; Hutchings A; Butcher G Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):1-7. PubMed ID: 1741739 [TBL] [Abstract][Full Text] [Related]
27. Measurment of rhesus monkey (Macaca mulatta) apolipoprotein B in serum by radioimmunoassay: comparison of immunoreactivities of rhesus and human low density lipoproteins. Karlin JB; Juhn DJ; Fless G; Scanu AM; Rubenstein AH J Lipid Res; 1978 Feb; 19(2):197-206. PubMed ID: 204718 [TBL] [Abstract][Full Text] [Related]
28. Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B. Watt TS; Watt RM Proc Natl Acad Sci U S A; 1983 Jan; 80(1):124-8. PubMed ID: 6185956 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. Albers JJ; Lodge MS; Curtiss LK J Lipid Res; 1989 Sep; 30(9):1445-58. PubMed ID: 2600545 [TBL] [Abstract][Full Text] [Related]
30. Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Corsini A; Mazzotti M; Villa A; Maggi FM; Bernini F; Romano L; Romano C; Fumagalli R; Catapano AL Atherosclerosis; 1992 Mar; 93(1-2):95-103. PubMed ID: 1596308 [TBL] [Abstract][Full Text] [Related]
31. Modulation of the expression of human LDL-Apo B-100 epitopes by lipids and apolipoproteins. Harduin P; Tailleux A; Fruchart JC; Fievet C Arterioscler Thromb; 1993 Apr; 13(4):529-35. PubMed ID: 7682107 [TBL] [Abstract][Full Text] [Related]
32. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins. Viens L; Lagrost L J Lipid Res; 1997 Jun; 38(6):1129-38. PubMed ID: 9215541 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of monoclonal antibodies to human plasma low density lipoproteins. A requirement for lipids to maintain antigenic structure. Patton JG; Alley MC; Mao SJ J Immunol Methods; 1982 Dec; 55(2):193-203. PubMed ID: 6186741 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies can precipitate low-density lipoprotein. I. Characterization and use in determining apolipoprotein B. Marcovina S; France D; Phillips RA; Mao SJ Clin Chem; 1985 Oct; 31(10):1654-8. PubMed ID: 3930091 [TBL] [Abstract][Full Text] [Related]
35. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins. Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009 [TBL] [Abstract][Full Text] [Related]
36. Immunochemical evidence that human apoB differs when expressed in rodent versus human cells. Wang X; Chauhan V; Nguyen AT; Schultz J; Davignon J; Young SG; Boren J; Innerarity TL; Rutai H; Milne RW J Lipid Res; 2003 Mar; 44(3):547-53. PubMed ID: 12562832 [TBL] [Abstract][Full Text] [Related]
37. Expression of apolipoprotein B epitopes in very low density lipoprotein subfractions. Studies with monoclonal antibodies. Tikkanen MJ; Cole TG; Hahm KS; Krul ES; Schonfeld G Arteriosclerosis; 1984; 4(2):138-46. PubMed ID: 6200098 [TBL] [Abstract][Full Text] [Related]
38. Antigenic mapping of human low density lipoprotein with monoclonal antibodies. Tikkanen NJ; Dargar R; Pfleger B; Gonen B; Davie JM; Schonfeld G J Lipid Res; 1982 Sep; 23(7):1032-8. PubMed ID: 6183385 [TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction: effects of LDL oxidation. Negri S; Roma P; Fogliatto R; Uboldi P; Marcovina S; Catapano AL Atherosclerosis; 1993 Jun; 101(1):37-41. PubMed ID: 7692863 [TBL] [Abstract][Full Text] [Related]